Velashape III receives FDA Approval
It was only a few days ago that Syneron Medical, the innovative manufacturers of Velashape, VelaSmooth and Ultrashape, announced the FDA clearance of their latest body contouring non invasive system , Velashape III! Velashape III also got CE Mark approval (a mandatory conformity marking for certain products sold within the European Economic Area)! Now Syneron has a new, powerful weapon in their arsenal to provide body contouring and cellulite treatment solutions!
Ruthie Amir, Global Vice President of Clinical affairs spoke about the Velashape III Clinical study: “In a VelaShape III clinical study of forty-two patients an average abdominal circumference reduction of 2.6 cm was recorded post 10 weeks following a single treatment,” and added “Within the same study, we uncovered that 100 percent of the patients responded to the single treatment protocol with an abdominal circumference reduction of at a least 1.5 cm, with results seen as early as two weeks.”
Velashape III is the 3rd generation of the prominent Velashape platform based on the elos® technology.
Finally Dr. Lori Brightman, among the leading investigators for the Velashape III states: “In clinical trials we found that we can achieve a quicker temperature end point in a matter of minutes with VelaShape III as opposed to the prolonged time required by the previous device,” and adds “By reaching temperature endpoint quicker, practitioners can use the valuable time to maintain the necessary temperature to effectively complete the treatment in a much shorter session.”
Here at LipoAdvisor.com we hope that when Velashape III arrives in the real market it will receive a feedback similar of that of the clinical studies!